Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dobutamine and sublingual microcirculation after esophagectomy
NL-OMON35417Recruiting
- Sponsor
- University Medical Center of Southern Nevada
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dobutamine in esophageal cancer (2 arms), sponsored by University Medical Center of Southern Nevada. Primary endpoints: Change in sublingual functional capillary density, Change in perfused vessel density and 1 more. Started Mar 2010; status: recruiting.
02
Drugs
dobutamine
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on NL-OMON35417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35417.